#72 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
Clinicians need to understand extraction methods and resulting cannabinoid-to-terpene profiles because they directly affect pharmacokinetics, efficacy, and adverse effects in patients. Different extract types (solvent-based, CO2, distillate) deliver varying ratios of active compounds, which influences onset time, duration, and the entourage effect, making product selection critical for dosing and therapeutic outcomes. This knowledge enables clinicians to counsel patients on which product types may better suit specific conditions and help patients make informed choices in jurisdictions where cannabis is legally accessible.
This article categorizes cannabis extract types based on their cannabinoid and terpene composition profiles, distinguishing between steam-distilled essential oils containing only volatile terpenes and solvent or CO2-based extracts like live resin and high-terpene full-spectrum extracts that retain both cannabinoids and terpenes. Understanding these extraction methodologies is clinically relevant because different extract compositions may produce varying pharmacological effects and patient outcomes, with the terpene-cannabinoid ratio potentially influencing therapeutic efficacy for conditions such as pain, anxiety, or inflammation. The selection of extract type directly impacts the chemical composition that reaches the patient, which affects dosing precision and predictability of clinical effects. Clinicians should recognize that products labeled identically may have substantially different chemical profiles depending on extraction method, which complicates standardization and evidence-based prescribing. For practitioners working with cannabis-based therapeutics, requesting third-party laboratory analysis of extract composition including both cannabinoid content and major terpene profiles enables more informed product selection aligned with individual patient needs and desired therapeutic targets.
“The extraction methods described here produce very different chemical profiles, and while we have some observational data on how patients report using these products, we frankly lack the controlled human trials needed to make evidence-based claims about which extract type is ‘best’ for any particular condition or patient. What we can say is that understanding cannabinoid and terpene composition matters clinically, but individual response varies enormously, so any selection process should start with patient-specific factors rather than extraction method alone.”
💊 As cannabis products proliferate in the retail market with increasingly specialized extract types—from terpene-only distillates to full-spectrum concentrates—clinicians should recognize that product labeling and marketing claims often outpace rigorous clinical evidence on comparative efficacy and safety. The distinction between extraction methods (solvent-based, CO2, steam distillation) affects cannabinoid and terpene profiles, which theoretically influences pharmacologic effects, yet most clinical trials still rely on standardized whole-plant preparations or isolated compounds rather than these commercial extracts. Patients may self-select products based on marketing narratives about “entourage effects” or superiority claims without evidence of clinical benefit over simpler formulations, while variable regulation means composition and potency labeling can be unreliable across jurisdictions. When counseling patients using or considering cannabis products, clinicians should acknowledge the lack of standardized evidence comparing extract types for specific conditions
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
